ライフサイエンスコーパス: number of death

1 ebolaviruses in terms of mortality rate and number of deaths.

2 enterocyte apoptosis and greatly reduced the number of deaths.

3 ol and Prevention to identify the causes and number of deaths.

4 art attack and stroke that result in a large number of deaths.

5 is unlikely to be fulfilled, as only a small number of deaths (1% in the United Kingdom) occur in cir

6 There was no difference in the total number of deaths (101 vs 96 for tamoxifen vs raloxifene)

7 significant between-group differences in the number of deaths (19 [12%] in the liraglutide group vs 1

8 ort, there was more than double the expected number of deaths (2.05, 1.83-2.26).

9 stroke (37% and 47% increase, respectively), number of deaths (21% and 20% increase), and DALYs lost

10 The numbers of deaths--243 in the zoledronic acid group and

11 at 5 years and suffered only about half the number of deaths (25 vs. 46) during the period of observ

12 regnancy (35.7 weeks versus 37.0 weeks), the number of deaths (4 versus 1), final degree of heart blo

13 f diabetes, which accounted for an increased number of deaths (8% and 10%, respectively).

14 of 0.20 in relative risks almost doubled the number of deaths (97% overestimation).

15 andardized mortality ratio (the ratio of the number of deaths among handgun purchasers to the number

16 Increases in the incidence of cases and the number of deaths among infants during the 1990s primaril

17 stimate the prevalence, healthcare costs and number of deaths among people with chronic obstructive p

18 The increase in number of deaths among UN peacekeeping personnel since 1

19 The rising number of deaths among United Nations (UN) peacekeeping

20 The small number of deaths among women (n = 29) limited statistica

21 hould be taken with caution, given the small number of deaths analyzed.

22 The actual number of deaths and each cause were obtained and the pr

23 The absolute number of deaths and hospitalizations averted because of

24 n/blinded follow-up of > or =6 weeks; 3) the number of deaths and modes of death were reported or cou

25 ear regression to examine the time trends in number of deaths and place of death, and Poisson regress

26 ectional study: (1) an estimate of the total number of deaths and the proportion unreported by each s

27 The number of deaths and the sample size of each study arm w

28 sis showed a significant association between number of deaths and the strength (P<.001) and duration

29 The small number of deaths and the uncertainty in both diagnosis a

30 The numbers of deaths and all-cause, pregnancy-related morta

31 wide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disrupt

32 previous studies to estimate changes in the numbers of deaths and in life years and life expectancy

33 th impact assessment methodology to estimate numbers of deaths and other adverse health outcomes that

34 ed 44.9% (95% CI: 44.2%, 45.4%) of the total number of deaths, and The Counted documented 93.1% (95%

35 age with quotes from district leaders on the numbers of deaths, and editorials on the failure of the

36 by two-thirds, is only possible if the high numbers of deaths are addressed by maternal, newborn, an

37 The total number of deaths associated with dialysis-requiring AKI

38 he past decade in the United States, and the number of deaths associated with dialysis-requiring AKI

39 From 2003-2013, the number of deaths associated with HCV has now surpassed 6

40 According to our estimates, the total number of deaths at ages 5-14 years in low-income and mi

41 lity (YLLs) were computed by multiplying the number of deaths at each age by a reference life expecta

42 There was an increased number of deaths at the highest dose level.

43 We calculated the change in the number of deaths attributable to climate-related changes

44 stimates may significantly underestimate the number of deaths attributable to smoking.

45 Largest numbers of deaths attributable to this risk factor from

46 Primary outcomes were the number of deaths attributed to coronary heart disease, s

47 dose after 12 weeks of age would reduce the number of deaths averted by approximately 20%.

48 The total estimated number of deaths averted in the year 2003 was 90,043.

49 ow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio

50 re in the scenarios resulted in an increased number of deaths being prevented, meaning that midwifery

51 11134 men were traced, and observed numbers of deaths between 1952 and 1997 were compared wi

52 The observed number of deaths by underlying cause were compared with

53 en younger than 5 years and birth rates, the numbers of deaths by cause were calculated for countries

54 Based on projected numbers of deaths by cause, years of life lived with dis

55 ed updated numbers of child deaths to derive numbers of deaths by causes.

56 Because a large number of deaths can be attributable to depression after

57 ry occupation, they found an increase in the number of deaths caused by circulatory system diseases (

58 The already-alarming number of deaths caused by malaria is increasing, caused

59 The incidence of and number of deaths caused by pancreatic tumours have been

60 ords into 15 distinct strata and reduced the number of death certificate requests by 76%.

61 false, or questionable matches to reduce the number of death certificate requests to state offices.

62 d consistently higher mortality and absolute number of deaths compared with low-risk patients using o

63 period from 1995 through 2000, yet the total number of deaths continued to increase.

64 d in many regions of the world, the absolute number of deaths continues to increase, with the majorit

65 d focus on perioperative mortality, a larger number of deaths could be avoided by focusing quality in

66 proximately 92% of the estimated decrease in number of deaths could be explained by the model; the re

67 duction in hospital acquired infections, the number of deaths could be reduced if healthcare provider

68 When calculated as the annual number of deaths divided by the total number of inpatien

69 = 1.1) and a nonsignificant increase in the number of deaths due to cancers of the bronchus and lung

70 The number of deaths due to CVD (SMR = 1.02, 95% CI = 0.9-1.

71 he authors found that there was an increased number of deaths due to digestive diseases (SMR = 1.7, 9

72 a District of Ghana were identified, and the number of deaths due to rotavirus disease was estimated

73 With the number of deaths due to stroke decreasing, more individu

74 The number of deaths during a median follow-up of 3.5 years

75 The number of deaths during follow-up was 10,624 in the 1976

76 We aimed to estimate the global number of deaths during the first 12 months of virus cir

77 We then compared the number of deaths expected during the holiday period, giv

78 sion line to daily mortality to estimate the number of deaths expected during the holiday period, usi

79 lculation will not consistently estimate the number of deaths expected in the absence of exposure bec

80 acteristics was used to predict the expected number of deaths for each TC.

81 The number of deaths for which CLD was listed as a contribut

82 We aimed to estimate life tables and annual numbers of deaths for 187 countries from 1970 to 2010.

83 es of the risks, and derive estimates of the numbers of deaths for 1990 and 2010 by applying those ri

84 nstrated that acadesine decreased by 89% the number of deaths from 13.3% (13 deaths/98 MIs) in the pl

85 The expected number of deaths from all causes, all cancers, and ovari

86 The number of deaths from an index cancer did not differ sig

87 difference was seen among the groups in the number of deaths from any cause (169 deaths overall; P=0

88 by 54,000 to 99,000 and to reduce the annual number of deaths from any cause by 44,000 to 92,000.

89 tene group vs. 88 in the placebo group); the number of deaths from cancer (386 vs. 380), deaths from

90 proach for decreasing both the incidence and number of deaths from cancer.

91 ral Europe and Western Europe did the annual number of deaths from cardiovascular disease actually de

92 s, and more than half of the increase in the number of deaths from circulatory system diseases was a

93 difference between the observed and expected number of deaths from coronary heart disease in 2000 was

94 Oral rehydration therapy has reduced the number of deaths from dehydration caused by infection wi

95 Most of the increase in the number of deaths from digestive diseases was caused by c

96 and the smallest absolute decline was in the number of deaths from hyperglycemic crisis (-2.7; 95% CI

97 Number of deaths from liver disease, total costs, and cu

98 ning with low-dose CT prevented the greatest number of deaths from lung cancer among participants who

99 e incidence of lung cancer, it increased the number of deaths from lung cancer, in particular deaths

100 has contributed to a global increase in the number of deaths from malaria.

101 .52, p=0.01), mainly as a result of a higher number of deaths from non-small-cell lung cancer in the

102 associated with a reduction in the expected number of deaths from ovarian cancer in the cohort as a

103 biturates to benzodiazepines has reduced the number of deaths from pharmaceutical self-poisoning.

104 A plot of the annual rates of change in the number of deaths from pneumonia was used to generate hyp

105 creening rates in the control group, the low number of deaths from prostate cancer, and the relativel

106 Number of deaths from self-administration of lethal medi

107 However, given the number of deaths from stroke in the present cohort, a sm

108 risk localized prostate cancer decreases the number of deaths from this disease.

109 The numbers of deaths from adverse events (31 [5%] vs 35 [6%

110 The highest numbers of deaths from all causes and from heart disease

111 With increasing numbers of deaths from cancer, palliative care should be

112 y patterns of female workers were different: Numbers of deaths from homicide and unintentional trauma

113 Action and shooting games led to the largest numbers of deaths from violent acts, and we found a sign

114 e costly transfer of patients and reduce the numbers of deaths; however, further study will be requir

115 The total number of deaths in 2001 attributed to CHD in patients o

116 Epidemiologists often compare the observed number of deaths in a cohort with the expected number of

117 lated as the ratio of observed deaths to the number of deaths in an age-matched and sex-matched UK po

118 al model was developed to estimate the total number of deaths in children according to provinces, age

119 We did the following to derive the number of deaths in children aged 1-59 months: we used v

120 -2004 in the UK and caused an unusually high number of deaths in children.

121 deaths due to smoking increases, the annual number of deaths in China that are caused by tobacco wil

122 common seasonal pathogens, we estimated the number of deaths in elderly persons attributable to viru

123 The number of deaths in hepatitis C virus (HCV)-infected per

124 ed, and partly because of an increase in the number of deaths in infants sleeping with their parents

125 ding the donor pool, and its use reduces the number of deaths in patients awaiting orthotopic liver t

126 Failure to rescue was the number of deaths in patients with complications divided

127 le way to consistently estimate the expected number of deaths in such settings, and we illustrate the

128 The total number of deaths in the 2 groups was identical (TIPS vs.

129 We compared the observed number of deaths in the days preceding MI symptom onset

130 There were significant increases in the number of deaths in the first week of the month for many

131 tates between 1973 and 1988, we compared the number of deaths in the first week of the month with the

132 A small number of deaths in the general population of patients w

133 will, in the foreseeable future, reduce the number of deaths in the industrialized world from cardio

134 aths in the first week of the month with the number of deaths in the last week of the preceding month

135 wever, these results were limited by the low number of deaths in the NET-PD LS-1.

136 ent data monitoring committee found a higher number of deaths in the rilotumumab group than in the pl

137 A substantial number of deaths in the United States could potentially

138 The number of deaths in this cohort was 3969 (13% mortality)

139 e HZ vaccination program, the average annual number of deaths in which HZ was reported as the underly

140 There were similar numbers of deaths in all 3 arms (5, 5, and 4, respective

141 Updated total numbers of deaths in children aged 0-27 days and 1-59 mo

142 survey to the 2010 UN estimates of absolute numbers of deaths in India to estimate the number of sui

143 Final estimates were checked to ensure that numbers of deaths in specific age-sex groups did not exc

144 t factors and birth numbers to the change in numbers of deaths in under-5 age groups from 1990 to 201

145 While the number of deaths increased steadily over time, heroin us

146 Survival of FL cells is determined by a number of death-inhibiting proteins, among which bcl-xL

147 In the United States, the number of deaths is higher in the first week of the mont

148 The small number of deaths limited the statistical power of the an

149 Final analysis after the preplanned number of deaths (n = 110) occurred after a median follo

150 0001), whereas the crude case fatality rate (number of deaths/number of cases) fell from 51.0% to 45.

151 from 1980 to 1989 had 28.9 times the excess number of deaths observed for survivors diagnosed either

152 ty for a 7-year observation period using the number of deaths observed in SLaM records compared with

153 ver 60 years, almost 30% of the total excess number of deaths observed were due to heart disease.

154 s, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers a

155 period, given the null hypothesis, with the number of deaths observed.

156 mber of deaths in a cohort with the expected number of deaths, obtained by multiplying person-time ac

157 Equal numbers of deaths occurred during classes or other schoo

158 Approximately equal numbers of deaths occurred inside school buildings (n =

159 admissions was not due to an increase in the number of deaths of patients with acute coronary syndrom

160 ay 0 (11.2 per 1000 livebirths); the highest number of deaths on day 0 was seen in southern Asia (n=3

161 e size of the candidate waiting list and the number of deaths on the waiting list are progressively i

162 the total patients on the waiting list, the number of deaths on the waiting list increased from 196

163 The number of deaths on treatment did not differ between the

164 ical trial failed to show a reduction in the number of deaths or complications with the addition of s

165 re favorable outcomes and no increase in the number of deaths or vegetative states among the patients

166 dom error (which, in general, requires large numbers of deaths or of some other relevant outcome).

167 ects were seen with either antibiotic on the number of deaths, other medical conditions, behavioural

168 Although a higher number of deaths overall occurred in the 1 cm group comp

169 noncardiovascular deaths (36.5% of the total number of deaths) (P=0.0008).

170 The number of deaths per 1000 live births was 275 (95% confi

171 For other drug overdose deaths, the mean number of deaths per day was 0.08 (SD = 0.28) on hot day

172 the proportion of violent game play and the number of deaths per minute of play.

173 For each winter, we estimated the number of deaths per month in excess of a base-line leve

174 On average across cities, the number of deaths (per 1,000 deaths) attributable to each

175 ated proportion of avoidable deaths, a total number of deaths possibly averted in the previous year w

176 d number of hospital deaths was close to the number of deaths predicted by the model, but when tested

177 he range of estimated lower- and upper-bound number of deaths prevented per year with intensive SBP c

178 The potential numbers of deaths prevented or postponed as a result of

179 ses, is capable of cleaving and activating a number of death proteins in target cells.

180 The numbers of deaths (r=0.40, P=0.03) and years of life los

181 were summarized using risk ratios (RRs) for number of deaths/recurrences and hazard ratios (HRs), wi

182 However, the theoretical number of deaths reduced by eliminating physical inactiv

183 ainly accounted for by the relatively higher number of deaths related to human immunodeficiency virus

184 Importantly, the number of deaths related to infections was significantly

185 126 recruits [51%]); however, a substantial number of deaths remained unexplained (44 of 126 recruit

186 The total annual number of death reports generally decreased during the l

187 We aimed to estimate the number of deaths that could be averted and the financial

188 y treatable conditions was estimated and the number of deaths that could have been avoided by providi

189 The number of deaths that occurred during treatment or less

190 enting a 28% (95% CI 26-33) reduction in the number of deaths that would be avoided because of change

191 amples collected in 1996 and ascertained the number of deaths through 2010.

192 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 mil

193 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 mil

194 The excess number of deaths was 13 for the first postoperative year

195 5% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100).

196 The expected number of deaths was 87 (standardized mortality ratio [S

197 The average number of deaths was about 5500 per day, or about 165,00

198 At week 60, the number of deaths was higher in the ozanezumab group (20

199 The mean number of deaths was highest in December at 1808 and Jan

200 The number of deaths was limited among subgroup analyses.

201 The number of deaths was not significantly different in the

202 The number of deaths was similar in the two groups.

203 31)I treatment, in absolute terms the excess number of deaths was small, and the underlying thyroid d

204 gical death rate was 1% (four patients); the number of deaths was too small for multivariate analysis

205 For 13 causes with low observed numbers of deaths, we developed negative binomial models

206 -methadone and forced-withdrawal groups, the number of deaths were one and zero, non-fatal overdoses

207 Beyond 30 days, a substantial number of deaths were related to the operation, especial

208 The numbers of deaths were as follows: 581 placebo-treated (

209 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2)

210 noncardiovascular deaths (47.5% of the total number of deaths), whereas in the rate-control arm, ther

211 We then compared the numbers of deaths with those given by the UN WPP itself

212 units (ICU) because of anaphylaxis, and the number of deaths within 10 days of presentation to the e

213 t and 45 percent, respectively), as were the numbers of deaths within 30 days after surgery.

214 Numbers of deaths within 7 days were increased (250/2807

215 nd devastating disease, such that the annual number of deaths (world-wide) from tobacco-related disea

216 us vaccine, we aimed to update the estimated number of deaths worldwide in children younger than 5 ye

217 s a severe medical condition causing a large number of deaths worldwide.

218 to the human brain and has been linked to a number of deaths worldwide.

219 fectious disease responsible for the highest number of deaths worldwide.

220 t in females and accounts for second highest number of deaths, worldwide.